Susanne Malander
Overview
Explore the profile of Susanne Malander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Corvigno S, Fernebro J, Karlsson J, Mezheieusky A, Martin-Bernabe A, De La Fuente L, et al.
Gynecol Oncol
. 2025 Feb;
193:148-155.
PMID: 39914230
Objective: Studies have implied that fibroblasts may act as regulators of immune cells in the tumor microenvironment (TME). We investigated the clinical relevance of fibroblast activation protein (FAP) positive stroma...
2.
Kjeldsen M, Jorgensen M, Gronseth D, Schonemann-Lund M, Nyvang G, Aaquist Haslund C, et al.
Cancer Res Commun
. 2024 Nov;
4(12):3190-3200.
PMID: 39591206
The irregular response to PARPi in HRD-positive and -negative tumors highlights the need for identifying additional biomarkers. This study explores the mutational landscape beyond HRD status in AOC, ultimately advancing...
3.
Norbeck A, Bengtsson J, Malander S, Asp M, Kannisto P
Acta Oncol
. 2024 Sep;
63:728-735.
PMID: 39319937
Background: Patients with advanced ovarian cancer (AOC) undergoing surgery are often subjected to red blood cell (RBC) transfusions. Both anemia and RBC transfusion are associated with increased morbidity. The aim...
4.
Asp M, Mockute I, Masback A, Liuba K, Kannisto P, Malander S
J Multidiscip Healthc
. 2023 May;
16:1367-1377.
PMID: 37215751
Purpose: Tru-cut biopsy is a minimally invasive technique used to obtain tissue samples for the diagnosis of tumors, especially in patients where primary surgery is not indicated. The aim of...
5.
Norbeck A, Asp M, Carlsson T, Kannisto P, Malander S
J Multidiscip Healthc
. 2023 May;
16:1239-1248.
PMID: 37163196
Purpose: The majority of women with ovarian cancer are diagnosed in late stages. Most women do have symptoms prior to diagnosis, sometimes several months before the diagnosis. The aim of...
6.
Asp M, Peber E, Kannisto P, Masback A, Malander S
Acta Oncol
. 2022 May;
61(7):785-792.
PMID: 35611589
Background: Ovarian Cancer (OC) constitute the eighth most common cancers among women worldwide. Surgery remains the cornerstone in the management of OC. Intraoperative frozen section (FS) diagnosis is widely used...
7.
Asp M, Malander S, Bengtsson J, Sartor H, Kannisto P
Anticancer Res
. 2022 Apr;
42(5):2541-2551.
PMID: 35489749
Background/aim: Residual disease (RD) after primary debulking surgery (PDS) is a prognostic factor for survival in advanced ovarian cancer (AOC). This study aimed to examine whether the tumor extent affects...
8.
Asp M, Malander S, Wallengren N, Pudaric S, Bengtsson J, Sartor H, et al.
Arch Gynecol Obstet
. 2022 Mar;
306(4):1235-1243.
PMID: 35235024
Purpose: Epithelial ovarian cancer is usually diagnosed in the advanced stages. To choose the best therapeutic approach, an accurate preoperative assessment of the tumour extent is crucial. This study aimed...
9.
Baath M, Jonsson J, Westbom Fremer S, De La Fuente L, Tran L, Malander S, et al.
Genes (Basel)
. 2021 Jun;
12(5).
PMID: 34069138
Overexpression of the receptor tyrosine kinase MET has been linked to poor survival in several cancer types, and MET has been suggested to interact with stem cell networks. In vitro...
10.
Leandersson P, Hogberg T, Dickman P, Malander S, Borgfeldt C
BMC Cancer
. 2021 Apr;
21(1):465.
PMID: 33902507
Background: Despite improved surgical and oncological treatment, ovarian cancer continues to be the most lethal of the gynecologic malignancies. We aimed to analyze survival trends in epithelial ovarian cancer with...